- Home
- SLN vs ZTEK Comparison
SLN vs ZTEK Comparison
Compare SLN & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- ZTEK
- Stock Information
- Founded
- SLN 1994
- ZTEK 2008
- Country
- SLN United Kingdom
- ZTEK Canada
- Employees
- SLN N/A
- ZTEK N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- SLN Health Care
- ZTEK Industrials
- Exchange
- SLN Nasdaq
- ZTEK Nasdaq
- Market Cap
- SLN 165.3M
- ZTEK 165.9M
- IPO Year
- SLN N/A
- ZTEK N/A
- Fundamental
- Price
- SLN $5.41
- ZTEK $1.49
- Analyst Decision
- SLN Buy
- ZTEK
- Analyst Count
- SLN 5
- ZTEK 0
- Target Price
- SLN $32.60
- ZTEK N/A
- AVG Volume (30 Days)
- SLN 170.8K
- ZTEK 44.7K
- Earning Date
- SLN 05-08-2025
- ZTEK 06-26-2025
- Dividend Yield
- SLN N/A
- ZTEK N/A
- EPS Growth
- SLN N/A
- ZTEK N/A
- EPS
- SLN N/A
- ZTEK N/A
- Revenue
- SLN $27,701,000.00
- ZTEK $44,936.00
- Revenue This Year
- SLN N/A
- ZTEK N/A
- Revenue Next Year
- SLN N/A
- ZTEK N/A
- P/E Ratio
- SLN N/A
- ZTEK N/A
- Revenue Growth
- SLN N/A
- ZTEK 92.38
- 52 Week Low
- SLN $1.97
- ZTEK $0.50
- 52 Week High
- SLN $22.47
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- SLN 64.31
- ZTEK 49.24
- Support Level
- SLN $4.69
- ZTEK $1.52
- Resistance Level
- SLN $6.35
- ZTEK $1.62
- Average True Range (ATR)
- SLN 0.53
- ZTEK 0.10
- MACD
- SLN 0.08
- ZTEK -0.03
- Stochastic Oscillator
- SLN 62.25
- ZTEK 33.33
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.